AI-Accelerated Development, FDA-Ready Evidence

An established global medical device manufacturer sought AlvaMed’s support in assessing a new web-based medical device software product being developed for a future FDA 510(k). Generative AI had been used to accelerate portions of software development and supporting documentation. The result was a substantial initial software documentation package, but the manufacturer needed to understand whether […]

Subscribe To AlvaMed's Newsletter

This field is for validation purposes and should be left unchanged.
A monthly analysis of the medical device industry, quality and regulatory developments, and other useful information for industry professionals. (Contact details are never shared outside our organization.)